The Balance between Energy, Environmental Security, and Technical Performance: The Regulatory Challenge of Nanofluids.

Nowadays, numerous studies on nanomaterials (NMs) and Nanofluids (NFs) are account a plethora of applications. With the scientific society's common goal of fulfilling the target of sustainable development proposed by the UN by 2030, it is necessary to combine efforts based on the scientific and technological knowledge already acquired, to apply these new systems with safety. There are thousands of publications that examine the use of NFs, their benefits and drawbacks, properties, behaviors, etc., but very little is known about the safety of some of these systems at a laboratory and industrial scale. What is the correct form of manipulating, storing, or even destroying them? What is their life cycle, and are they likely to be reused? Depending on the nanoparticles, the characteristics of the base fluid (water, propylene glycol, or even an ionic liquid) and the addition or not of additives/surfactants, the safety issue becomes complex. In this study, general data regarding the safety of NF (synthetic and natural) are discussed, for a necessary reflection leading to the elaboration of a methodology looking at the near future, intended to be sustainable at the level of existing resources, health, and environmental protection, paving the way for safer industrial and medical applications. A discussion on the efficient use of nanofluids with melanin (natural NM) and TiO2 in a pilot heat collector for domestic solar energy applications illustrates this methodology, showing that technical advantages can be restricted by their environment and safety/security implications.

Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency.

Measuring lymphocyte response to mitogens and antigens is a mainstay of screening for cellular immunodeficiency. Few reports analyze performance as a screening tool in diverse patient cohorts. We studied proliferation assays performed at Children's Hospital Boston from 1996 to 2003 using mitogens phytohemagglutinin (PHA), concanavalin A (CONA) and pokeweed mitogen, and antigens tetanus (TT) and diphtheria (DT) toxoids, and compared a subset of patients with T cell dysfunction with adult controls using receiver operating characteristic analysis. Results were correlated with clinical data. CONA was superior to PHA in identifying patients with immunodeficiency. TT was second best. Interpretation based on raw CPM, a stimulation index, or reference to simultaneous controls all performed equally. Combining data from multiple mitogens and/or antigens did not enhance performance. Proliferation testing is a useful component of screening for cellular immunodeficiency, but is not a sensitive predictor of cellular immune compromise or risk of opportunistic infection.